Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 Update and consensus statement from the Canadian Pain Society

Pain Res Manag. 2015 Jan-Feb;20(1):46-7. doi: 10.1155/2015/438597.

Abstract

The Canadian Pain Society (CPS) hosted its first Study Day in Toronto in July 2014, attended by experts in various fields of pain management and research (listed below). The aim was to review the National Advisory Committee on Immunization guidelines and to prepare a CPS position statement concerning the use of the zoster vaccine in Canada.

Publication types

  • Consensus Statement
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Canada
  • Herpes Zoster Vaccine / therapeutic use*
  • Humans
  • Neuralgia, Postherpetic / prevention & control*

Substances

  • Herpes Zoster Vaccine